Transcatheter mitral valve edge-to-edge repair for severe mitral regurgitation in patients with HFpEF phenotype
M-TEER is an effective treatment for both severe primary and secondary MR in patients with HFpEF phenotype, significantly reducing MR and improving symptoms. The independent association of severe TR with increased all-cause mortality highlights the importance of timely intervention to prevent right heart failure and worse outcomes.
Authors
- Stephan Nienaber (ORCID: https://orcid.org/0000-0001-5779-7549)
- Matthieu Schäfer (ORCID: https://orcid.org/0000-0003-1875-1163)
- Johannes Dohr
- Richard J. Nies (ORCID: https://orcid.org/0000-0002-1336-6031)
- Clemens Metze (ORCID: https://orcid.org/0000-0001-8980-4598)
- Maria Isabel Körber (ORCID: https://orcid.org/0000-0001-9073-9279)
- Roman Pfister
- Christos Iliadis
- Jonathan Curio
- Stephan Baldus
Institutions
- University Hospital Cologne (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1007/s00392-026-02882-x
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00